Summary
Invesco NASDAQ Future Gen 200 ETF is an ETF - a fund traded on an exchange like a stock - run by Invesco. Positions inside: 208. The ten largest make up 7.9% of the fund.
- Yearly costs
- 0.20%
- Fund size
- $21.3M
- Positions
- 208
- Dividend yield
- 1.90%
- Running since
- 2022
What speaks for it
- Costs of 0.20% a year are below the middle of comparable funds (0.44%).
- Widely spread: the ten largest positions make up only 7.9% of the fund.
- Average yearly growth over the last three years: 24%.
What to watch
- 52% of the fund is in one sector (Healthcare).
- 84% of the fund is in one country (United States).
- In the last five years its price once dropped by 39% from its high.
- A small fund with $21.3M under management; small funds get closed more often.
- It trades little: only about $270.7K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -9.0%
- 3 months
- -6.8%
- This year
- +15%
- 1 year
- +12%
- 3 years
- +89%
- Avg. market cap
- $3.48B
- P/E
- -
- Forward P/E
- 13.0x
- P/S
- 0.8x
- P/B
- 1.8x
- P/FCF
- 11.5x
- EV/EBITDA
- 12.4x
- Dividend yield
- 0.81%
- ROIC
- 499.2%
- ROE
- 3.0%
- Gross margin
- 59.8%
- Operating margin
- -17.1%
- Net margin
- -27.5%
- Payout ratio
- -
- Net debt/EBITDA
- 5.0x
- Beta
- 1.75
Weighted average of the 50 largest companies, which make up 32% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Widely spread- 1 QTQTREX Quantum Ltd. QTEX 1.1%
- 2 IOIovance Biotherapeutics, Inc. IOVA 1.0%
- 3 PAPacific Biosciences of California, Inc. PACB 0.8%
- 4 PCPacira BioSciences, Inc. PCRX 0.8%
- 5 MYMyriad Genetics, Inc. MYGN 0.7%
- 6 GPGoPro, Inc. GPRO 0.7%
- 7 MXMaxLinear, Inc. MXL 0.7%
- 8 Turtle Beach Corp 0.7%
- 9 TTTTEC Holdings, Inc. TTEC 0.7%
- 10 SYSynaptics Incorporated SYNA 0.7%
Positions in the fund: 208. The ten largest make up 7.9% of it.
Composition as of Oct 17, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 52%
- Technology 31%
- Industrials 5.4%
- Consumer cyclical 5.3%
- Communication services 2.6%
- Other 3.6%
By country
- United States 84%
- Israel 4.0%
- Canada 3.0%
- United Kingdom 2.3%
- Other countries 7.0%
By company size
- Large cap 2.5%
- Mid cap 21%
- Small cap 40%
- Micro cap 37%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (52%). Largest country: United States (84%). Largest size group: Small cap (40%).
What does it cost me?
Cheap- A year from $10,000
- $20.00
- Over 20 years
- $993
From every $10,000 invested the fund takes $20.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $993.
How has it done?
Growing over the long run- A year on average, 3 years
- +24%
- Deepest drop
- -39%
- Yearly volatility
- 26%
Average yearly growth over the last three years: 24%. Deepest drop in these years: 39% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 1.90%
- Payments a year
- 4
- Last payment
- $0.02
Over the last 12 months it paid $0.74 per share, which is 1.90% of today's price. The last payment was $0.02 on Sep 21, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $270.7K
- Shares a day
- 6.9K
On an average day about $270.7K of the fund changes hands.
How expensive are the companies inside?
Rather expensive- Average Bulios Score
- 46 out of 100
Weight by Bulios Fair Price
- Undervalued 32%
- Fairly valued 4.1%
- Overvalued 64%
By Fair Price, 64% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 32% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.